Brasada Capital Management, LP Eli Lilly & CO Transaction History

Brasada Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $1.7 Million - $2.26 Million	-13,066 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $787,540 - $910,934	5,386 Added 70.13%	13,066 $1.93 Million
Q2 2020 Jul 14, 2020	BUY	$136.42 - $164.18 $1.05 Million - $1.26 Million	7,680 New	7,680 $1.26 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $3,494 - $3,915	-33 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $2,833 - $3,541	33 New	33 $4,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $29,683 - $35,040	-400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $32,776 - $35,156	400	400 $34,000

3,869

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.